CN108135930A - 使用亚氯酸盐治疗红细胞疾病和由其介导的适应症 - Google Patents

使用亚氯酸盐治疗红细胞疾病和由其介导的适应症 Download PDF

Info

Publication number
CN108135930A
CN108135930A CN201680061116.3A CN201680061116A CN108135930A CN 108135930 A CN108135930 A CN 108135930A CN 201680061116 A CN201680061116 A CN 201680061116A CN 108135930 A CN108135930 A CN 108135930A
Authority
CN
China
Prior art keywords
ions
pharmaceutical composition
diabetes
patient
chlorite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680061116.3A
Other languages
English (en)
Chinese (zh)
Inventor
派汶·马拉普雷萨万
弗里德里克-威廉·屈内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxo Translation Science Co ltd
Original Assignee
Oxo Chemie Thailand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxo Chemie Thailand Co Ltd filed Critical Oxo Chemie Thailand Co Ltd
Publication of CN108135930A publication Critical patent/CN108135930A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201680061116.3A 2015-08-20 2016-08-22 使用亚氯酸盐治疗红细胞疾病和由其介导的适应症 Pending CN108135930A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562207774P 2015-08-20 2015-08-20
US62/207,774 2015-08-20
PCT/IB2016/055011 WO2017029648A1 (en) 2015-08-20 2016-08-22 Use of chlorite to treat red blood cell diseases and indications mediated thereby

Publications (1)

Publication Number Publication Date
CN108135930A true CN108135930A (zh) 2018-06-08

Family

ID=56896735

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680061116.3A Pending CN108135930A (zh) 2015-08-20 2016-08-22 使用亚氯酸盐治疗红细胞疾病和由其介导的适应症

Country Status (6)

Country Link
US (1) US11813234B2 (enExample)
EP (1) EP3337489B1 (enExample)
JP (2) JP6900596B2 (enExample)
CN (1) CN108135930A (enExample)
RU (1) RU2018109574A (enExample)
WO (1) WO2017029648A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112168841A (zh) * 2019-07-05 2021-01-05 卢序 一种增加人一氧化氮生物利用度的方法
CN112386606A (zh) * 2019-08-19 2021-02-23 卢序 一种有第二信使作用增加积极氧化压力的氧化剂的用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120134929A1 (en) * 2009-08-06 2012-05-31 Mcgrath Michael S Treatment of macrophage-related disorders
US20130177629A1 (en) * 2011-12-22 2013-07-11 Nuvo Research Gmbh Liposomal compositions
WO2013109949A1 (en) * 2012-01-19 2013-07-25 Ibt Usa Inc. Therapeutic uses of tetrachlorodecaoxygen (tcdo)
US20140000925A1 (en) * 2012-06-28 2014-01-02 Hubbell Incorporated Electrical box extender assembly

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU754928B2 (en) 1997-10-06 2002-11-28 Oxo Chemie Ag Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
US20040224306A1 (en) 1999-11-30 2004-11-11 Frederich-Wilhelm Kuhne Evaluating and predicting clinical outcomes by gene expression analysis
EP1558237A4 (en) * 2002-09-27 2007-01-17 Martek Biosciences Corp IMPROVED BLOOD SUGAR CONTROL F RPRU-DIABETES AND / OR DIABETES TYPE II USING DOCOSAHEXAENSURE
EP2081021A4 (en) * 2006-10-16 2014-07-23 Sekisui Chemical Co Ltd HEMOGLOBIN DETERMINATION PROCESS
WO2008145376A1 (en) 2007-06-01 2008-12-04 Dimethaid Ag Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
US20140287064A1 (en) * 2009-04-28 2014-09-25 Karen G. Swenholt Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument
US20110118180A1 (en) * 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Method of treatment of diabetes type 2 comprising add-on therapy to metformin
CA2945179A1 (en) * 2014-05-16 2015-11-19 Michael S. Mcgrath Methods and compositions for treatment of macrophage-related disorders

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120134929A1 (en) * 2009-08-06 2012-05-31 Mcgrath Michael S Treatment of macrophage-related disorders
US20130177629A1 (en) * 2011-12-22 2013-07-11 Nuvo Research Gmbh Liposomal compositions
WO2013109949A1 (en) * 2012-01-19 2013-07-25 Ibt Usa Inc. Therapeutic uses of tetrachlorodecaoxygen (tcdo)
US20140000925A1 (en) * 2012-06-28 2014-01-02 Hubbell Incorporated Electrical box extender assembly

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112168841A (zh) * 2019-07-05 2021-01-05 卢序 一种增加人一氧化氮生物利用度的方法
CN112386606A (zh) * 2019-08-19 2021-02-23 卢序 一种有第二信使作用增加积极氧化压力的氧化剂的用途

Also Published As

Publication number Publication date
JP2021130664A (ja) 2021-09-09
CA2995659A1 (en) 2017-02-23
RU2018109574A (ru) 2019-09-23
JP2018523711A (ja) 2018-08-23
RU2018109574A3 (enExample) 2020-02-27
US11813234B2 (en) 2023-11-14
JP6900596B2 (ja) 2021-07-07
US20180243334A1 (en) 2018-08-30
EP3337489A1 (en) 2018-06-27
WO2017029648A1 (en) 2017-02-23
BR112018003227A2 (pt) 2018-09-25
EP3337489B1 (en) 2023-01-18

Similar Documents

Publication Publication Date Title
JP5475671B2 (ja) ピロホスフェートを含む滅菌透析溶液
Misra et al. PEG ylated carboxyhemoglobin bovine (SANGUINATE): results of a phase I clinical trial
KR20080082674A (ko) 철을 투여하기 위한 방법 및 조성물
Schmitt et al. Is there such a thing as biocompatible peritoneal dialysis fluid?
CN101716182B (zh) 含盐酸二甲双胍和维生素b12的组合药物
JP2021130664A (ja) 赤血球疾患およびそれによって媒介される症状を治療するための亜塩素酸塩の使用
Arulkumaran et al. Management of the dialysis patient in general intensive care
Lanzkron et al. Polymerized human Hb use in acute chest syndrome: a case report
CN113476398B (zh) 一种稳定安全的阿加曲班注射液和制备方法
WO2003068247A1 (en) Eye installation based on iodine anions
CA2995659C (en) Use of chlorite to treat red blood cell diseases and indications mediated thereby
BR112018003227B1 (pt) Uso de clorito para tratar doenças dos glóbulos vermelhos e indicações mediadas desta forma
CN104055763A (zh) 甘氨酸在葛根素注射剂中的应用
US20090236284A1 (en) Removal of substances in dialysis solutions and dialysis components by ion exchange adsorption
RU2802154C1 (ru) Способ заместительной селенотерапии при септической энцефалопатии
JP2006305345A (ja) カルボニルストレス状態改善剤、および腹膜透析液
Manley et al. One Drug, Different Mechanisms of Side Effects: Linezolid-Induced Thrombocytopenia and Type B Lactic Acidosis: SA-PO257
Watanabe et al. Exploring the Potential of Renal Dopaminergic System-Mediated Enhancement in Sodium Excretion by Canagliflozin: SA-PO256
Stankus et al. Drug-Drug Interaction Between Phosphate Binders and Daprodustat in ASCEND-D: SA-PO255
Vecchio et al. Metformin and lactic acidosis
GÜLDAL et al. Hypercalemıa In The Emergency Department
CN104042602A (zh) 谷氨酸钠在葛根素注射剂中的应用
Shuster Quinine-induced Disseminated Intravascular Coagulation Fatal Lactic Acidosis with Metformin and Antiretrovirals Valsartan-Induced Angioedema Red Blood Cell Aplasia with Mycophenolate Mofetil Thalidomide-Induced Bradycardia
Kosnadi et al. Hypovolemic shock complicating nephrotic syndrome in a child
Malone et al. An unconscious and unresponsive young man

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20210514

Address after: CHIANG MAI

Applicant after: Frederic - William Cune

Address before: Bangkok Thailand

Applicant before: OXO CHEMIE (THAILAND) Co.,Ltd.

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20230801

Address after: Wanzleiben Boulder, Germany

Applicant after: OXO Translation Science Co.,Ltd.

Address before: CHIANG MAI

Applicant before: Frederic - William Cune

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180608